Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 3/2010

01-06-2010 | Correspondence

Secondary bacterial pneumonia due to Staphylococcus aureus complicating 2009 influenza A (H1N1) viral infection

Authors: C. Tsigrelis, M. Mohammad, H. S. Fraimow, R. P. Dellinger, D. Marchesani, A. C. Reboli

Published in: Infection | Issue 3/2010

Login to get access

Excerpt

In April 2009, a novel influenza virus (2009 influenza A [H1N1] virus) was first reported in humans [1]. This was followed by case series of patients with severe 2009 influenza A (H1N1) viral infection [2‐5]. Although secondary bacterial pneumonia due to Staphylococcus aureus was a major cause of death in patients with influenza during prior pandemics [6], it has not been well characterized during the current pandemic [2‐5]. We therefore describe two patients with early onset secondary bacterial pneumonia due to S. aureus that occurred as a complication of 2009 H1N1 viral infection. …
Literature
1.
Centers for Disease Control and Prevention (CDC). Swine influenza A (H1N1) infection in two children—Southern California, March–April 2009. MMWR Morb Mortal Wkly Rep 2009;58:400–2.
2.
Centers for Disease Control and Prevention (CDC). Hospitalized patients with novel influenza A (H1N1) virus infection—California, April–May, 2009. MMWR Morb Mortal Wkly Rep 2009;58:536–41.
3.
Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection—Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009;58:749–52.
4.
Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605–15.CrossRefPubMed
5.
Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, INER Working Group on Influenza, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680–9.CrossRefPubMed
6.
Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198:962–70.CrossRefPubMed
7.
Kapelusznik L, Patel R, Jao J, et al. Severe pandemic (H1N1) 2009 influenza with false negative direct fluorescent antibody assay: Case series. J Clin Virol. 2009;46:279–81.CrossRefPubMed
8.
Bogart DB, Liu C, Ruth WE, Kerby GR, Williams CH. Rapid diagnosis of primary influenza pneumonia. Chest. 1975;68:513–7.CrossRefPubMed
9.
Robertson L, Caley JP, Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet. 1958;2:233–6.CrossRefPubMed
10.
Schwarzmann SW, Adler JL, Sullivan RJ Jr, Marine WM. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968–1969. Arch Intern Med. 1971;127:1037–41.CrossRefPubMed
11.
Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003–04 influenza season. Emerg Infect Dis. 2006;12:894–9.PubMed
12.
Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza—Louisiana and Georgia, December 2006–January 2007. MMWR Morb Mortal Wkly Rep 2007;56:325–9.
Metadata
Title
Secondary bacterial pneumonia due to Staphylococcus aureus complicating 2009 influenza A (H1N1) viral infection
Authors
C. Tsigrelis
M. Mohammad
H. S. Fraimow
R. P. Dellinger
D. Marchesani
A. C. Reboli
Publication date
01-06-2010
Publisher
Urban and Vogel
Published in
Infection / Issue 3/2010
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-010-0009-0

Other articles of this Issue 3/2010

Infection 3/2010 Go to the issue

Clinical and Epidemiological Study

Interferon-γ releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants

Case Report

Novel influenza A (H1N1) encephalitis in a 3-month-old infant

Correspondence

Successful treatment of three children with post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis

Clinical and Epidemiological Study

Device-associated infections in the intensive care units of Cyprus: results of the first national incidence study

Brief Report

External ventricular and lumbar drainage-associated meningoventriculitis: prospective analysis of time-dependent infection rates and risk factor analysis

Brief Report

The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-d-glucan in patients without risk factors for invasive fungal infections

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits